Selisistat (EX 527) is a potent and selective inhibitor of the SIRT1 class III histone deacetylase enzyme. EX 527 has been used a powerful tool for studying the relationship between SIRT1 and cell regulation. The deacetylation of cortactin, a protein responsible for rearrangements of the actin cytoskeleton, is associated with cell motility and possibly tumorigenesis, and blocking of this deacetylation by EX 527 correlated to a decrease in cell motility. Blocking of SIRT1 by EX 527 also demonstrated that deacetylation of the important tumor suppressor protein p53 is mediated by SIRT1 as well.
Int J Biochem Cell Biol. 2022 Aug;149:106246.
Adipose improves muscular atrophy caused by Sirtuin1 deficiency by promoting mitochondria synthesis
Selisistat (EX 527) purchased from AbMole
Int J Biol Sci. 2022 Jan 31;18(4):1594-1611.
Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway
Selisistat (EX 527) purchased from AbMole
Int Immunopharmacol. 2022 Feb;103:108456.
Differential regulation of lipopolysaccharide-induced IL-1β and TNF-α production in macrophages by palmitate via modulating TLR4 downstream signaling
Selisistat (EX 527) purchased from AbMole
Mol Neurobiol. 2018 Apr;55(4):3067-3078.
17β-Estradiol via SIRT1/Acetyl-p53/NF-kB Signaling Pathway Rescued Postnatal Rat Brain Against Acute Ethanol Intoxication
Selisistat (EX 527) purchased from AbMole
Free Radic Biol Med. 2018 Oct 17.
Resveratrol protects photoreceptors by blocking caspase- and PARP-dependent cell death pathways.
Selisistat (EX 527) purchased from AbMole
Cell Experiment | |
---|---|
Cell lines | NCI-H460 cells, MCF-7 cells, U-2 OS cells, or HMEC cell lines |
Preparation method | Cell viability assay. NCI-H460 cells, MCF-7 cells, U-2 OS cells, or HMEC were plated at 2,000 cells per well in opaque-walled 96-well plates (Corning) for the viability assay and 800 cells per well in 96-well Cytostar-T scintillating microplates (Amersham) for the proliferation assay. Cells were incubated for 1 day (NCI-H460) or 2 days (MCF-7, U-2 OS, and HMEC) prior to exposure to DNA-damaging agents and deacetylase inhibitors. All experiments were performed in triplicate.For viability assays, cells were treated with the indicated compounds for 48 h. Cell viability was then determined using the Cell Titer-Glo luminescent assay (Promega), which measures total ATP levels as an index of cell number. Luminescence was measured on a Luminoskan Ascent (ThermoLabSystems). |
Concentrations | 0~100 μM |
Incubation time | 48 h |
Animal Experiment | |
---|---|
Animal models | Male Sprague-Dawley rats (8 weeks old, 200–250 g) and C57/B6 mice (8 weeks old) model |
Formulation | DMSO |
Dosages | 5-10 μg in a total volume of 5 μL |
Administration | Intracerebroventricular administration |
Molecular Weight | 248.71 |
Formula | C13H13ClN2O |
CAS Number | 49843-98-3 |
Solubility (25°C) | DMSO 25 mg/mL |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
Related HDAC Products |
---|
Psammaplin A
Psammaplin A is a Marine metabolite that acts as a potent inhibitor of HDAC and DNA methyltransferases. Psammaplin A is a highly selective HDAC1 inhibitor with an IC50 of 0.9 nM, which is 360 times more selective to HDAC1 than DAC6 and more than 1000 times less potent to HDAC7 and HDAC8. |
FNDR-20123 free base
FNDR-20123 free base is an effective, safe and first-in-class anti-malarial HDAC inhibitor with an IC50 of 31 nM for Plasmodium and 3 nM for human HDAC. |
FNDR-20123
FNDR-20123 is an effective, safe and first-in-class anti-malarial HDAC inhibitor with IC50 of 31 nM for Plasmodium and 3 nM for human HDAC. |
GSK3117391
GSK3117391 (GSK3117391A, HDAC-IN-3) is a potent histone deacetylase (HDAC) inhibitor. |
Tubastatin A TFA
Tubastatin A TFA (Tubastatin A trifluoroacetate salt) is a potent and selective HDAC6 inhibitor with IC50 of 15 nM in a cell-free assay. It is selective against all the other isozymes (1000-fold) except HDAC8 (57-fold). Tubastatin A promotes autophagy and increases apoptosis. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.